Cellular Biomedicine Group to Present at the 2016 World Stem Cell Summit
November 28, 2016 07:36 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Nov. 28, 2016 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged in the...
Cellular Biomedicine Group Announces Results of 2016 Annual General Meeting
September 09, 2016 16:05 ET
|
Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biomedicine firm engaged in the...
Cellular Biomedicine Group Reports First Quarter 2016 Financial Results and Provides Business Highlights
May 09, 2016 16:01 ET
|
Cellular Biomedicine Group Inc.
– Reported Positive Clinical Data from Phase IIb trial of ReJoin® haMPC therapy– Expanded Stem Cell Platform with the Launch of New Allogeneic Clinical Trial– Closed Strategic Investment of $43.13...